Summary & Overview
Acute Leukemia with Other Procedures: Inpatient Reimbursement Overview
DRG 850 encompasses inpatient stays for acute leukemia when other significant procedures are performed, reflecting combined oncology care and procedural resource use. Correct assignment affects inpatient reimbursement under Medicare prospective payment by aligning payment with expected services and intensity of care.
DRG 850 Overview
DRG 850 covers inpatient admissions for patients with acute leukemia who undergo other significant procedures during the same hospital stay, typically including procedures related to chemotherapy administration, central venous access, or supportive care interventions. This Diagnosis-Related Group groups cases with resource use above routine medical management but without the presence of major complications or comorbidities that would place them in a higher-severity category. It matters for Medicare payment because it helps determine the bundled prospective payment for the hospital stay based on expected resource consumption associated with both the leukemia diagnosis and the additional procedures. Accurate coding of the procedures and clinical diagnoses is essential to assign the correct Diagnosis-Related Group and receive appropriate reimbursement.